Home » Poniard Pharmaceuticals Cuts Positions, Focuses on Oncology
Poniard Pharmaceuticals Cuts Positions, Focuses on Oncology
Poniard Pharmaceuticals Inc. said it will concentrate its cash resources on the clinical and commercial development of its late-stage oncology candidate, picoplatin, and cut about 12 percent of its staff, or eight employees.
San Francisco Business Times
San Francisco Business Times
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May